Genome Canada is pleased to announce a partnership with the ERA-NET consortium “E-Rare-3” and participation in the 2015 "European Research Projects on Rare Diseases" Joint Transnational Call.
Genome Canada wishes to commend the Government of Canada on a comprehensive new strategy – Seizing Canada’s Moment: Moving Forward in Science Technology and Innovation 2014.
In particular, we are pleased to see prominent recognition of the role that new technologies, including genomics, can play in transforming our economy and enhancing Canadians’ quality of life.
During a keynote address at Genomics: the Power and the Promise conference, the Honourable Ed Holder, Minister of State (Science and Technology) highlighted that, with sustained federal investment in genomics, Canada has built a formidable research capacity in this cutting-edge field.
This Funding Opportunity is to create the consortium structure for the Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC), one of CIHR's Roadmap Signature Initiatives. Epigenetics is the study of changes in the regulation of gene activity and expression that are not dependent on alterations in gene sequence. Epigenetics provides a compelling model for how environmental influences throughout life can have long-long effects on human health.
Génome Québec commends the dedication of the federal government, which today launched a call for proposals for projects aiming to reduce infant mortality and improve the health of mothers and children in developing countries.
Genome Canada, in partnership with the Canadian Institutes of Health Research, is developing a funding opportunity intended to support a single pan-Canadian program to develop a comprehensive strategy that will enable the sharing of genomic and clinical datasets across Canada and around the globe in a responsible, secure and effective manner.
We at Genome Canada wish to offer our sincere condolences to the family members and friends of former finance minister Jim Flaherty. Mr. Flaherty was an exceptional leader and visionary. He had a profound understanding of the social and economic return on investment that could be yielded from scientific research investments.
The Honourable Ed Holder, Minister of State (Science and Technology) and Dr. Pierre Meulien, President and CEO of Genome Canada, are pleased to announce the first 12 projects selected for funding under Genome Canada’s Genomic Applications Partnership Program (GAPP). The announcement was made at Wallenstein’s Feed & Supply Ltd., where the Minister toured the company’s animal feed production facilities.